|
Myxofibrosarcoma of
the Orbit: An Underrecognized Entity? Case Report and Review of the
Literature.Ophthalmology.
2007 Dec 18.
PURPOSE: To
describe the clinicopathologic and immunohistochemical features of a
rare case of myxofibrosarcoma (MFS) involving the orbit. DESIGN:
Retrospective interventional case report and review of literature.
METHODS: The clinical history, systemic imaging studies, and
histopathologic results of the orbital biopsy are reviewed. MAIN
OUTCOME MEASURES: Clinical, radiologic, and histologic features of
MFS. RESULTS: A 63-year-old Chinese male sought treatment for a
history of rapidly progressive proptosis associated with decreased
vision in the left eye over 10 days. Magnetic resonance imaging of
the orbit revealed a homogenous mass extending to the optic canal.
The mass was excised partially and was submitted for histologic and
ultrastructural examination. Histologic testing revealed features of
MFS with characteristic diffuse proliferation of atypical,
spindle-shaped fibroblasts with prominent myxoid stroma. Tumor cells
were reactive for vimentin. Ultrastructural examination revealed
spindle-shaped tumor cells, rich in dilated rough endoplasmic
reticulum and prominent vacuoles. CONCLUSIONS: For historical
reasons, MFS involving the orbit is likely to be underrecognized and
categorized erroneously as malignant fibrous histiocytoma or other
soft tissue sarcoma. Although orbital MFS is an extremely rare
diagnosis, ophthalmologists should be aware of the possibility and
consider a diagnosis of MFS when an adult seeks treatment for an
orbital tumor with aggressive growth.
Epithelioid
variant of myxofibrosarcoma: expanding the clinicomorphologic
spectrum of myxo-fibrosarcoma in a series of 17 cases.
Am J Surg Pathol. 2007 Jan;31(1):99-105.
Myxofibrosarcoma (MFS) is one of the most common soft tissue
sarcomas of elderly patients and has a predilection for the limbs.
Herein, we report a previously undescribed variant of MFS showing
epithelioid morphology. Seventeen cases diagnosed as epithelioid MFS
were retrieved from the authors' files from among 570 cases of MFS.
Hematoxylin and eosin-stained sections were reexamined and
immunostains for pan-keratin (15 cases), S-100 protein (15), desmin
(15), and alpha-smooth muscle actin (13) were performed. Nine
patients were men and 8 were women (age range 43 to 89 y; median
63.5). Fifteen patients presented with a mass, and in 2 of these
there was also pain. Duration of symptoms varied from 1 to 24 months
(median 3). Tumor size ranged from 2 to 15 cm (median 6.75). In 10
cases, the tumor was located in subcutaneous tissue and in 6 cases
it was subfascial. The majority of the tumors were located on the
limbs (8 lower extremities and 6 upper extremities) followed by neck
(1), scalp (1), and trunk (1). Follow-up was available for 14
patients (range 2 to 240 mo; median 16). Twelve patients were
treated by surgery followed by chemotherapy and/or radiation (8
cases). One patient received chemotherapy after an incisional biopsy
and 1 patient was treated by surgery alone. Ten patients (71.4%)
developed local recurrences. Seven patients (50%) developed
metastases to lungs or retroperitoneum. Five patients (35.7%) have
died of disease so far. Two patients were lost to follow-up.
Morphologically, 14 cases were high grade, 2 were intermediate, and
1 was low grade. Tumors were characterized by a multinodular,
infiltrating growth pattern with alternation of hypercellular and
hypocellular myxoid areas; the latter showed prominent curvilinear
vessels. Neoplastic cells were arranged singly and in small clusters
in the myxoid areas or formed sheets in the hypercellular areas,
where they showed epithelioid morphology with round nuclei,
vesicular chromatin, prominent nucleoli, and moderate amounts of
eosinophilic cytoplasm. The epithelioid areas were generally
multifocal with admixed areas of conventional MFS. Immunostains were
negative for all markers studied. Differential diagnosis included
carcinoma, melanoma, myoepithelial carcinoma, pleomorphic
liposarcoma, and pleomorphic rhabdomyosarcoma. In conclusion,
epithelioid MFS is a rare variant of MFS, accounting for <3% of MFS
in consultation material. Its natural history seems more aggressive
than usual high-grade MFS, with approximately 70% local recurrence
and 50% metastases, even within a relatively short follow-up period. |